Abiopharma

🔍 Hou Tianyu (Executive)

Company: Sea Ltd (SE)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Sold 14,289 shares of Class A ordinary shares at $119.78 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 25,711.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 5,611 shares of Class A ordinary shares at $120.41 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 20,100.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 100 shares of Class A ordinary shares at $121.24 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: false | shares_owned_after: 20,000.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Holds 0 shares of Class A ordinary shares (Direct)
  Date: 2026-08-17 | Code: H | shares_owned_after: 2,383,015.00

Footnotes:

• F1: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by a BVI entity controlled by the Reporting Person on March 19, 2026.
• F2: Represents the weighted average price of shares sold at prices that ranged from $119.16 to $120.155. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
• F3: Represents the weighted average price of shares sold at prices that ranged from $120.16 to $121.05.
• F4: Represents the weighted average price of shares sold at prices that ranged from $121.19 to $121.24.